Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response Adapted Lenalidomide in Older Adults with Newly Diagnosed Multiple Myeloma
NCT01054144Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Jan 2010
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by Moffitt Cancer Center. Started Jan 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01054144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01054144.